| Name | Somatostatin Receptor Modulator Therapy in Neurodegeneration |
| Summary | Therapeutic targeting of somatostatin receptors (SSTR1-5) for Alzheimer's disease, Parkinson's disease, CBS, PSP, ALS, FTD, and Huntington's disease. Covers mechanism of action, receptor subtype targeting, clinical candidates, and pipeline. |
| Related Diseases | BIPOLAR_DISORDER |
| Linked Hypotheses | 1 hypotheses |
No comments yet. Be the first to comment!
No comments yet. Be the first to comment!